Status:
NOT_YET_RECRUITING
Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses
Lead Sponsor:
National Taipei University of Nursing and Health Sciences
Collaborating Sponsors:
Chang Gung Memorial Hospital
Conditions:
Prostate Cancer (Adenocarcinoma)
Eligibility:
All Genders
20-90 years
Phase:
NA
Brief Summary
This study aims to help patients with prostate cancer and their spouses cope better with the challenges of cancer by learning and supporting each other together. The investigators will test an 8-week ...
Detailed Description
Objective: To evaluate the effectiveness of a Dyadic Co-learning Intervention for patients with prostate cancer and their spouses, focusing on physical symptoms, emotional well-being, and resilience....
Eligibility Criteria
Inclusion
- For Patients:
- Diagnosed with prostate cancer by a board-certified urologist.
- Has either decided on a treatment plan or completed treatment within the past two years.
- Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.
- For Spouses:
- Must be a cohabiting spouse of the prostate cancer patient and aged 20 years or older.
- Must have a Barthel Index score of 91 or above, indicating good functional independence.
Exclusion
- Either the patient or the spouse will be excluded if:
- Diagnosed with another type of cancer.
- Diagnosed with cognitive impairment or a psychiatric disorder, such as dementia, depression, or anxiety.
Key Trial Info
Start Date :
September 16 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT07196488
Start Date
September 16 2025
End Date
July 31 2026
Last Update
September 29 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.